It was reported that SPAG5 has participated in growth and progression of various tumors, which was overexpressed in breast cancer (11, 12), osteosarcoma (13), lung cancer (14), bladder urothelial carcinoma (15), prostate cancer (16), and cervical cancer (17). This evidence concerns the gene SPAG5 and cervical cancer.